Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hengli Lu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
ACS Nano|December 30, 2025
Muscle-Targeted Nanocomposite Therapy Alleviates Age-Related Sarcopenia via Antioxidant and Metabolic ReprogrammingZhang Liu, Zile Shen, Hengli Lu, et al.
Cancer Science|July 29, 2024
Blocking CXCR4-CARM1-YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysisZihua Li, Hengli Lu, Yiwei Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2024
Microneedle-Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K-Akt-mTOR PathwayZihua Li, Hengli Lu, Limin Fan, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 21, 2024
Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three-in-One Therapy Strategy for OsteosarcomaHengli Lu, Zihua Li, Zhengwei Duan, et al.
Biomaterials|January 25, 2022
Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunityKaiyuan Liu, Yuxin Liao, Zifei Zhou, et al.
Biomaterials|April 5, 2026
Molybdenum-based antioxidative nanomedicine fighting against retinal pigment epithelium degenerationYahan Ju, Hengli Lu, Siwei Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
Alkaline Phosphatase-Activated NIR-II AIEgens Nanosystem for Surgical and Postoperative Closed-Loop Therapy of Advanced OsteosarcomaKaiyuan Liu, Ruotong Li, Li Zhang, et al.
Nature Communications|May 12, 2026
Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammationLian Cui, Hengli Lu, Jiangluyi Cai, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ACS Nano|December 30, 2025
Muscle-Targeted Nanocomposite Therapy Alleviates Age-Related Sarcopenia via Antioxidant and Metabolic ReprogrammingZhang Liu, Zile Shen, Hengli Lu, et al.
Cancer Science|July 29, 2024
Blocking CXCR4-CARM1-YAP axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysisZihua Li, Hengli Lu, Yiwei Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 29, 2024
Microneedle-Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K-Akt-mTOR PathwayZihua Li, Hengli Lu, Limin Fan, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 21, 2024
Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three-in-One Therapy Strategy for OsteosarcomaHengli Lu, Zihua Li, Zhengwei Duan, et al.
Biomaterials|January 25, 2022
Photothermal-triggered immunogenic nanotherapeutics for optimizing osteosarcoma therapy by synergizing innate and adaptive immunityKaiyuan Liu, Yuxin Liao, Zifei Zhou, et al.
Biomaterials|April 5, 2026
Molybdenum-based antioxidative nanomedicine fighting against retinal pigment epithelium degenerationYahan Ju, Hengli Lu, Siwei Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 20, 2026
Alkaline Phosphatase-Activated NIR-II AIEgens Nanosystem for Surgical and Postoperative Closed-Loop Therapy of Advanced OsteosarcomaKaiyuan Liu, Ruotong Li, Li Zhang, et al.
Nature Communications|May 12, 2026
Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammationLian Cui, Hengli Lu, Jiangluyi Cai, et al.
Pageof 2